The effects of hypoxia on the modulation of human TREK-1 potassium channels

Journal of Physiology

Volumn 562, Issue 1, 2005, Pages 205-212

  Caley, Alex J ^a   Gruss, Marco ^a,b   Franks, Nicholas P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ARACHIDONIC ACID; HALOTHANE; NEUROPROTECTIVE AGENT; NITROUS OXIDE; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; RILUZOLE; SODIUM CHLORIDE; VOLATILE AGENT; OXYGEN; POTASSIUM CHANNEL TREK 1; UNCLASSIFIED DRUG;

ARTICLE; BRAIN HYPOXIA; CONTROLLED STUDY; EMBRYO; GAS; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE ELECTROPHYSIOLOGY; METABOLIC ACIDOSIS; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE; NEUROMODULATION; OXYGEN CONCENTRATION; POTASSIUM CHANNEL TREK 1; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TEMPERATURE MEASUREMENT; ACIDOSIS; CHEMOSENSITIVITY; DRUG TARGETING; HIGH TEMPERATURE; MEMBRANE BIOLOGY; PROTEIN FAMILY; PROTEIN FUNCTION;

ACIDOSIS; ANESTHETICS, INHALATION; ANOXIA; ARACHIDONIC ACID; CELL LINE; ELECTROPHYSIOLOGY; HALOTHANE; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; OXYGEN; POTASSIUM CHANNELS, TANDEM PORE DOMAIN;

EID: 13444301518     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.076240     Document Type: Article

References (18)

1. Bonnet U, Bingmann D & Wiemann M (2000). Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones. Eur Neuropsychopharmacol 10, 97-103.
2. Dings J, Meixensberger J, Jager A & Roosen K (1998). Clinical experience with 118 brain tissue oxygen partial pressure catheter probes. Neurosurgery 43, 1082-1095.
3. + channels TREK-1 and TRAAK. Mol Pharmacol 57, 906-912.
4. Goldstein SA, Bockenhauer D, O'Kelly I & Zilberberg N (2001). Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2, 175-184.
5. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65, 443-452.
6. + channel involved in neuroprotection and general anesthesia. EMBO J 23, 2684-2695.
7. Hoffman WE, Charbel FT & Edelman G (1996). Brain tissue oxygen, carbon dioxide, and pH in neurosurgical patients at risk for ischemia. Anesth Analg 82, 582-586.
8. Lesage F (2003). Pharmacology of neuronal background potassium channels. Neuropharmacology 44, 1-7.
9. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem 275, 28398-28405.
10. Maingret F, Patel AJ, Lesage F, Lazdunski M & Honoré E (1999). Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 274, 26691-26696.
11. Meadows HJ, Benham CD, Cairns W, Gloger I, Jennings C, Medhurst AD, Murdock P & Chapman CG (2000). Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflugers Arch 439, 714-722.
12. + channels in central neuroprotection. J Physiol 548, 31-37.
13. Miller P, Peers C & Kemp PJ (2004). Polymodal regulation of hTREK1 by pH, arachidonic acid, and hypoxia: physiological impact in acidosis and alkalosis. Am J Physiol Cell Physiol 286, C272-C282.
14. + channels. Trends Neurosci 24, 339-346.
15. + channels. Nat Neurosci 2, 422-426.
16. Raventós J (1956). The action of fluothane - a new volatile anaesthetic. Br J Pharmacol 11, 394-410.
17. Roos A & Boron WF (1981). Intracellular pH. Physiol Rev 61, 296-434.
18. + conductances of rat cortical collecting duct principal cells. Pflugers Arch 428, 631-640.